Infectious Diseases Society Of America Guideline Update

The next time you take a careful travel history, think what it would be like to ask comedy writer Mike Reiss — he and his wife have been to more than a hundred countries, many of them far from the usual tourist routes. Paul Sax, MD, FIDSA, sits down with Reiss to discuss the good, the bad and the ugly. 

“If you have something to contribute, that contribution is going to be valued.” In 2019, Jasmine Marcelin, MD, FIDSA, became the youngest person to be elected to the IDSA Board of Directors. In this episode, Dr. Marcelin shares her journey, from experiencing “imposter syndrome,” balancing board work with a career and young children, and why age shouldn’t deter you from applying. 

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines.*This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.

IDSA President-Elect Steven K. Schmitt, MD, FIDSA and IDSA Immediate Past President Daniel P. McQuillen, MD, FIDSA discuss their experience as clinicians serving on the IDSA Board of Directors.   

The ID/EIS joint fellowship streamlines a career path for applicants interested in both the ID fellowship and EIS program. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Molly Paras, MD, Program Director of Massachusetts General Hospital/Brigham and Women’s Hospital Infectious Diseases Fellowship and Eric Pevzner, MD Chief of the Epidemiology and Laboratory Workforce Branch in the Division of Workforce Development at CDC about the new opportunity and the value it will bring to public health. To learn more, visit idsociety.org/ideisfellowship. 

The Bio-Preparedness Workforce Pilot Project was included in the BIO Preparedness Workforce Act that was passed by Congress at the end of 2022. In this episode, IDSA President Carlos del Rio, MD, FIDSA speaks with Paul Pottinger, MD, DTMH, FACP, FIDSA of the University of Washington and Emily Spivak, MD, MHS, FIDSA of the University of Utah about the program and how it will address ID workforce needs. Learn more about the Bio-Preparedness Workforce Pilot Project. 

Mowing a lawn in Martha's Vineyard and getting tularemia. Swimming in Lake Malawi and getting schistosomiasis. In a game that mirrors a fantasy sports draft, Paul Sax, MD, FIDSA and Rebeca Plank, MD, MPH take turns picking favorite ID associations.

IDSA President Carlos del Rio, MD, FIDSA, Wendy Armstrong, MD, FIDSA, FACP and Erin Bonura, MD, discuss medical education including the latest Match results, recruitment challenges and the work of IDSA’s Med Ed Community of Practice. 

IDSA President Carlos del Rio, MD, FIDSA, is joined by Anthony Fauci, MD, FIDSA, who will step down as NIAID director this month after 38 years, to discuss Dr. Fauci’s role as director, pandemic preparedness and what ID professionals can do to help recruit more medical students into the field.

IDSA President Carlos del Rio, MD, FIDSA recaps IDWeek 2022 with IDWeek Program Committee Chair  Adarsh Bhimraj, MD, FIDSA and Vice-Chair Heather Yun, MD. 

Mati Hlatshwayo Davis, MD, MPH and Jessica Snowden, MD, FIDSA share actions that providers and health systems can take to ensure equitable care for Native American and Alaska Native communities.

Igho Ofotokun, MD, FIDSA, principal investigator of the RECOVER study funded by NIH, and Alba Azola, MD, co-director of the Johns Hopkins Post-Acute COVID-19 Team, discuss the latest research on long COVID.

Infectious disease physicians Dr. Valeria Cantos and Dr. Paulina Rebolledo of Emory University School of Medicine discuss their work with the Latino Community Fund to bolster community awareness on COVID-19 boosters and antivirals. 

Kathryn Edwards, MD, FIDSA and Keipp Talbot, MD, FIDSA of Vanderbilt University School of Medicine discuss COVID-19 bivalent vaccine boosters, including how bivalent vaccines are used, the differences between the Moderna and Pfizer boosters and if boosters will become an annual occurrence. 

In honor of Hispanic Heritage Month, IDSA Board member Maximo Brito, MD, FIDSA and panelists Vincent Guilamo-Ramos, Ph.D. and Carina Marquez, MD discuss the rich diversity within Latinx communities, cultural practices to facilitate health interventions, leveraging community partnerships and how to support pathways for Latinx students entering the medical field. 

Mati Hlatshwayo Davis, MD, MPH and Tina Tan, MD, FIDSA discuss the impact COVID-19 has had on maternal mortality, the downstream effects from unequal access to care and how providers can advocate for health equity.    

Pediatric ID physicians Buddy Creech, MD, MPH, FPIDS, PIDS president, and Andi Shane, MD, MPH, discuss COVID-19's impact on the school year ahead. *This episode was recorded on August 9, 2022. 

In this rebroadcast of the COVID-19 Vaccination Education Roundtable Series, Mati Hlatshwayo Davis, MD, MPH and panelists discuss how to ensure COVID-19 vaccination equity for pediatric populations and ways to leverage the lessons learned to reduce the impact of future pandemics, particularly on marginalized and minoritized communities.

How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinical considerations for people with HIV and the broader impacts of the COVID-19 pandemic on the HIV community and efforts to end the HIV epidemic.

Pediatric infectious disease physicians Jason Newland, MD of Washington University of St. Louis and Buddy Creech, MD of Vanderbilt University Medical Center discuss the latest information on COVID-19 pediatric vaccination, including the recent approval of vaccines for children ages 0-5.